文献速递血栓与止血

我如何管理血友病携带者及血管性血友病患者的妊娠

How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease.
PubMed 文献 · Blood · 2020-01-01

本文综述遗传性出血性疾病女性(血友病A/B携带者及血管性血友病患者)妊娠与分娩的多学科管理,包括孕前遗传咨询、产前诊断及母婴分娩计划。近期回顾性研究显示即使遵循严格指南且凝血因子水平正常化,产后出血风险仍存在。文章描述作者当前的诊断与临床管理,并简要讨论通过提高分娩期间及产后目标因子水平来改善结局的可能干预措施。

要点

  • 血友病携带者及血管性血友病患者妊娠和分娩出血风险增加,需血液科、儿科血液科、临床遗传学、产科母胎医学及麻醉科多学科团队管理。
  • 最佳管理包括孕前遗传咨询、产前诊断程序及针对母婴的分娩治疗计划。
  • 近期回顾性研究显示,即使遵循严格指南且凝血因子水平正常化(妊娠诱导升高或分娩时输注凝血因子浓缩物),产后出血风险仍存在。

核心结论

  • 血友病携带者及血管性血友病患者妊娠和分娩需多学科管理,包括孕前遗传咨询、产前诊断及母婴分娩计划;近期回顾性研究显示即使遵循严格指南且凝血因子水平正常化,产后出血风险仍存在。

研究设计与样本

  • 本文为综述,描述作者当前对遗传性出血性疾病女性妊娠和分娩的诊断与临床管理,并简要讨论通过提高分娩期间及产后目标因子水平来改善结局的可能干预措施。

主要发现

  • 近期回顾性研究显示,即使遵循严格指南,这些女性仍存在产后出血风险。
  • 产后出血风险存在于凝血因子水平正常化时,无论正常化源于妊娠诱导的因子水平升高还是分娩时输注凝血因子浓缩物。

临床怎么用

  • 作者描述其当前对遗传性出血性疾病女性妊娠和分娩的诊断与临床管理,包括孕前遗传咨询、产前诊断程序及针对母婴的分娩治疗计划。
  • 作者简要讨论通过提高分娩期间及产后目标因子水平来改善当前策略结局的可能干预措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Women with inherited bleeding disorders, including carriers of hemophilia A and B, or with von Willebrand disease, have an increased risk of bleeding during pregnancy and delivery. The unborn child may also be affected by the bleeding disorder for which specific measures have to be considered. This requires a multidisciplinary approach, with a team that includes a hematologist, a pediatric hematologist, a clinical geneticist, an obstetrician-perinatologist, and an anesthesiologist. An optimal approach includes prepregnancy genetic counseling, prenatal diagnostic procedures, and a treatment plan for delivery for both the mother and child. Recent retrospective studies show that even if strict guidelines are followed, these women are still at risk of postpartum bleeding. This occurs even if coagulation factor levels are normalized, either due to the pregnancy-induced rise of factor levels or by infusion of coagulation factor concentrates at the time of delivery. In this article, we describe our current diagnostic and clinical management of pregnancy and delivery in women with inherited bleeding disorders. We also briefly discuss possible interventions to improve the outcome of current strategies by increasing target factor levels during and after delivery.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Leebeek FWG, Duvekot J, Kruip MJHA, et al. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease. Blood. 2020. PMID: 32797211. doi:10.1182/blood.2019000964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。